A phase II study of irinotecan as a third- or fourth-line treatment for advanced non-small cell lung cancer: NJLCG0703 - Concepedia

Concepedia

Publication | Closed Access

A phase II study of irinotecan as a third- or fourth-line treatment for advanced non-small cell lung cancer: NJLCG0703

12

Citations

28

References

2012

Year

Nobumichi Matsubara, Makoto Maemondo, Akira Inoue, Osamu Ishimoto, Kana Watanabe, Tomohiro Sakakibara, Tatsuro Fukuhara, Naoto Morikawa, Masashi Tanaka, Shunichi Sugawara,

Respiratory Investigation

OncologyMedicineFourth-line TreatmentPhase Ii StudyBronchial NeoplasmPharmacotherapyAnti-cancer AgentCancer TreatmentPharmacologyRadiation OncologyLung CancerCancer Growth

References

	Year	Citations

Page 1

Page 1